Given questions about how long the
vaccine is effective for, she questioned the
efficacy of giving shots to girls as young as 11 years old in parts of the world (such as the U.S.) where women regularly undergo safety Pap screening repeatedly over their lifetimes, saying that the chances of their contracting cervical cancer may be
less than the «small» risks associated with the
vaccine.
In the study, mice given a lethal dose of dengue virus
less than a week after receiving the protective DMAb were completely protected from lethal disease — significantly more rapid than
vaccine - driven protection, which can take weeks to months to reach peak
efficacy levels.